VEGFA and corneal neovascularization: For example, Moreno and others prepared thiolated CS-based hydrogels for the administration of two anti-vascular endothelial growth factor (anti-VEGF) protein drugs, ranibizumab and aflibercept, to treat choroidal or corneal neovascularization [265].